Medicine
Fosaprepitant 150 mg/5 mL powder for injection
Fosaprepitant 150 mg/5 mL powder for injection is a generic prescription medicine for intravenous use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Fosaprepitant for injection vials must be refrigerated, store at 2°C-8°C…
Key facts
- Active ingredient (INN)
- Fosaprepitant
- Brand
- Sold under the generic name
- Strength
- 150 mg/5 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial and 17 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaNovadoz PharmaceuticalsIndiaCamber PharmaceuticalsIndiaEugiaIndiaBluePoint LaboratoriesHikma PharmaceuticalsAvenacyBaxter HealthcareBE PharmaceuticalsBryant Ranch Prepack
- Origin register
- US FDA, United States
- Storage
- Fosaprepitant for injection vials must be refrigerated, store at 2°C-8°C (36°F-46°F). The reconstituted final drug solution is stable for 24 hours at ambient room temperature [at or below 25°C (77°F)].
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD12 Fosaprepitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 September 2019
- Identifiers
- RxCUI 1731077DailyMed set ID 7375ab3f-a6fc-4601-9415-07b4f681cdef, 21b08b87-70e3-4233-9531-dd6d84eab5d0, 679c195a-cf59-4ca5-aa05-fa35d08ddb5c +18NDC 71731-5111, 71839-104, 72162-2636 +18Application ANDA212143, ANDA212309, ANDA209965 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 mL in 1 vial | 43598-859-11 | Dr. Reddy's LaboratoriesIndia | 6 September 2019 |
| 1 vial in 1 carton / 1 mL in 1 vial | 43598-948-11 | Dr. Reddy's LaboratoriesIndia | 1 July 2020 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72205-054-01 | Novadoz PharmaceuticalsIndia | 12 May 2020 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72205-083-01 | Novadoz PharmaceuticalsIndia | 12 May 2020 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 31722-165-31 | Camber PharmaceuticalsIndia | 29 July 2021 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 55150-299-01 | EugiaIndia | 12 January 2021 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0143-9384-01 | Hikma Pharmaceuticals | 8 September 2020 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0143-9428-01 | Hikma Pharmaceuticals | 1 May 2021 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0338-0008-01 | Baxter Healthcare | 5 September 2019 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 71839-104-01 | BE Pharmaceuticals | 15 October 2019 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 71731-5111-1 | Chia Tai Tianqing Pharmaceutical Group | 16 March 2021 |
| 1 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 63323-972-10 | Fresenius Kabi | 5 September 2019 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 67457-889-10 | Mylan Institutional | 5 September 2019 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 67184-0540-1 | Qilu Pharmaceutical | 8 September 2020 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 68001-523-36 | BluePoint Laboratories | 2 February 2022 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 68001-675-25 | BluePoint Laboratories | 15 October 2025 |
| 1 vial in 1 carton / 5 mL in 1 vial | 83634-776-10 | Avenacy | 28 February 2024 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72162-2636-2 | Bryant Ranch Prepack | 6 May 2026 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72603-450-01 | Northstar Rx | 1 April 2025 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 16714-248-01 | NorthStar RxLLC | 28 January 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fosaprepitant 150 mg/5 mL powder for injection.
Other strengths and forms of Fosaprepitant
Clinical summary
Fosaprepitant is a substance P/neurokinin-1 receptor antagonist. It is available as powder for injection and injection for intravenous use. MedsAcross supplies Fosaprepitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FosaprepitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMEND prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Ivemend: European public assessment report (EPAR) · European Medicines Agency
Need Fosaprepitant 150 mg/5 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.